Immediate Impact

7 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
2023 Standout
2 intermediate papers

Works of Peter E. Haroldsen being referenced

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
2017
Genetic variation in arylN‐acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4‐diaminopyridine) phosphate
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Peter E. Haroldsen 168 132 62 20 369
Y.S. Choong 145 64 37 25 394
Vincent Croixmarie 263 90 18 9 407
J Horecký 86 39 19 22 343
Eric Burak 142 31 68 19 346
Jun-Ye MIAO 134 23 29 11 313
John R. Yandrasitz 204 30 42 18 375
C. Ray Tallent 74 57 23 19 319
N. Robinson 157 27 31 33 329
S.N. Rao 234 48 59 14 383
C. Stonier 82 22 111 16 307

All Works

Loading papers...

Rankless by CCL
2026